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The ubiquitously expressed ATPase inhibitory factor
1 (IF1) is a mitochondrial protein that blocks the
reversal of the F1Fo-ATPsynthase, preventing dissi-
pation of cellular ATP and ischemic damage. IF1 sup-
presses programmed cell death, enhancing tumor
invasion and chemoresistance, and is expressed in
various types of human cancers. In this study, we
examined its effect on mitochondrial redox bal-
ance and apoptotic cristae remodeling, finding that,
by maintaining ATP levels, IF1 reduces glutathione
(GSH) consumption and inactivation of peroxiredoxin
3 (Prx3) during apoptosis. This correlates with inhi-
bition of metallopeptidase OMA1-mediated process-
ing of the pro-fusion dynamin-related protein optic
atrophy 1 (OPA1). Stabilization of OPA1 impedes
cristae remodeling and completion of apoptosis.
Taken together, these data suggest that IF1 acts on
both mitochondrial bioenergetics and structure, is
involved in mitochondrial signaling in tumor cells,
and may underlie their proliferative capacity.
INTRODUCTION
Cancer is a complex disease that originates from the simulta-
neous deregulation of multiple signaling and metabolic path-
ways leading to uncontrolled cell growth and proliferation
(Vogelstein and Kinzler, 1993; Seyfried et al., 2014). Despite
the vast heterogeneity of genetic, epigenetic, and metabolic
changes from which cancers arise, tumor cells share a series
of common traits, known as the ‘‘hallmarks of cancer’’ (Hanahan
and Weinberg, 2011). Among these is the ability to evade
apoptosis and withstand both intracellular and extracellular
death signals. Mitochondria are central regulators of apoptosis,
during which they lose membrane integrity and release key pro-
apoptotic factors (Tait and Green, 2010; Martinou and Youle,Cell Re
This is an open access article under the CC BY-N2011). Mitochondria are dynamic organelles that fuse and divide
to form a constantly changing network, which modulates mito-
chondrial metabolism (Benard and Rossignol, 2008; Wester-
mann, 2012) and quality control (Twig and Shirihai, 2011; Ni
et al., 2015).
Proteins involved in the control of mitochondrial dynamics also
regulate apoptosis (Otera and Mihara, 2012). During apoptosis,
tubular mitochondria fragment into small isolated puncta (Frank
et al., 2001), the tightly packed lamellar cristae swell and mito-
chondrial inner membrane (MIM) organization is lost (Scorrano
et al., 2002). Apoptotic mitochondrial remodeling is mainly sus-
tained by recruitment of the pro-fission factor dynamin-related
protein 1 (Drp1) and proteolytic cleavage of the structural protein
optic atrophy 1 (OPA1).
The ATPase inhibitory factor 1 (IF1), which is upregulated in
many human carcinomas (Sa´nchez-Cenizo et al., 2010; Song
et al., 2014; Yin et al., 2015), is implicated in the control of
both mitochondrial bioenergetics and structure, by regulating
the activity and oligomerization of the F1Fo-ATPsynthase
(hereinafter referred to as ATP synthase) (Garcı´a et al., 2006;
Campanella et al., 2008). Furthermore, the level of IF1 expres-
sion in hepatocellular carcinomas, gliomas, and gastric cancers
correlates with aggressiveness and invasiveness of tumors
and poor prognosis in patients (Song et al., 2014; Yin et al.,
2015; Wu et al., 2015). We previously demonstrated that IF1
promotes cell survival against apoptosis by blocking mito-
chondrial remodeling (Faccenda et al., 2013b).This associates
with counteraction of Bax and Drp1 recruitment, hindering mito-
chondrial fission, permeabilization, and cytochrome c (cyt c)
release, which are key events of intrinsic apoptosis (Galluzzi
et al., 2015).
Cristae morphogenesis and structure are regulated by the
synergetic activity of OPA1 and the ATP synthase. While OPA1
oligomers guarantee formation and closure of the cristae junc-
tions, dimers of ATP synthase drive the invagination of the
MIM and form ribbons at the cristae tips that maintain their cur-
vature (Davies et al., 2012; Daum et al., 2013). Interestingly, by
binding to the ATP synthase, IF1 not only inhibits its hydrolytic
activity, but also stabilizes its dimerization (Tomasetig et al.,ports 18, 1869–1883, February 21, 2017 ª 2017 The Authors. 1869
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. The Oncogenic Potential of IF1
(A) Representative fluorescent IHC images of tissue sections of human breast IDC, from grade 1 to 3, and matched normal tissues (NT) and lymph node
metastasis (LNM), immunostained for IF1 and ATP5B. Images are presented as heatmaps, where the brightest pixels correspond to the areas of highest score
(ranging from 0 to 5,000 relative fluorescence units [RFU]; scale bars, 100 mm).
(B) Bar charts of IF1 (left) and ATP5B (middle) mean fluorescence intensities, and of IF1:ATP5B fluorescence intensity ratio (right), in the different groups,
normalized to grade 1. Data are presented as mean ± SEM; grade 1, n = 12; grade 2, n = 44; grade 3, n = 16, LNM, n = 36.
(C) Soft agar colony formation assay (scale bars, 100 mm).
(legend continued on next page)
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2002; Garcı´a et al., 2006). ATP hydrolysis induces a torque that
pulls the ATP synthase monomers apart and facilitates the bind-
ing of IF1, which then promotes formation of dimers and oligo-
mers by blocking the counterclockwise rotation of the F1 domain
(Buzhynskyy et al., 2007).
Taking this evidence into account, we hypothesized that IF1
can actively preserve the inner mitochondrial structure during
apoptosis by regulating OPA1-mediated control of mitochon-
drial dynamics. This, together with the previously demonstrated
regulation of Drp1 recruitment (Faccenda et al., 2013b), may be
key to IF1-mediated inhibition of cyt c release (Faccenda et al.,
2013a).
Here, we show that during apoptosis OPA1 processing is pre-
vented by IF1 through functional interplay with the stress-acti-
vated protease OMA1 (Anand et al., 2014; Jiang et al., 2014).
In parallel, IF1 counteracts glutathione (GSH) loss and drives
the ATP-dependent reactivation of the mitochondrial peroxidase
peroxiredoxin 3 (Prx3), which promote cell survival under redox
stress (Cunniff et al., 2014; Song et al., 2015). Consistent with
previous findings, this work demonstrates that IF1 counteracts
the structural remodeling of mitochondria during apoptosis
through concomitant regulation of both mitochondrial dynamics
and metabolism.
RESULTS
The IF1:ATP Synthase Expression Ratio Correlates with
Tumor Grade and Oncogenic Potential
A positive correlation between IF1 expression and cancer
aggressiveness, via sustenance of the invasive and migratory
phenotypes, has been recently proposed (Sa´nchez-Arago´
et al., 2013; Song et al., 2014; Yin et al., 2015; Wu et al., 2015).
Since malignancy-related changes in IF1 levels relative to the
ATP synthasemay contribute to tumor progression, we analyzed
whether the IF1:ATP synthase ratio of expression varies accord-
ing to tumor grade in invasive ductal carcinoma (IDC), the most
common type of breast cancer. Breast carcinoma tissue micro-
arrays (TMAs) with progressive changeswere immunostained for
IF1 and the ATP synthase, b subunit (Figures 1A and S1). Interest-
ingly, the IF1:ATP synthase expression ratio increases accord-
ingly to the degree of tumor dedifferentiation (Figure 1B). Our
results corroborate previous findings (Song et al., 2014; Yin
et al., 2015) and suggest a possible pro-tumorigenic metabolic
impact through aberrant regulation of the ATP synthase.
In order to prove the oncogenic potential of IF1, we then inves-
tigated the effect of IF1 loss on the in vitro and in vivo proliferative
capacity of cancer cells. By using stable knockdown (KD) HeLa
cells (Fujikawa et al., 2012) (Figure S2A) and transformed IF1
knockout (KO) mouse embryonic fibroblasts (MEFs) (Nakamura
et al., 2013) (Figure S2B), we observed a drastic decrease in
both anchorage-independent cell growth and xenograft tumor(D) Column diagram reporting the average number of visible colonies (Ø > 100 m
(E) Representative TEM images of control and IF1 KD HeLa cells at resting cond
(F) Bar charts of mean cristae number per mitochondrial area (left) and ratio betw
and tubular) cristae (right), before and after treatment with STS. Data are presen
(G) Xenograft analysis of nude mice inoculated with transformed WT and IF1 KO
(H) Column diagrams reporting the percentage of xenograft formation and the avgrowth (Figures 1C, 1D, 1G, 1H, and S2C), highlighting IF1 contri-
bution to unregulated proliferation of cancer cells.
According to recent evidence, increased IF1 levels confer a
growth advantage to cancer cells by inducing structural and
physiological alteration at the mitochondrial level (Sa´nchez-
Arago´ et al., 2012; Faccenda et al., 2013a). In particular, we
showed that IF1 expression level defines cell susceptibility to
apoptosis (Faccenda et al., 2013b) by modulating mitochondrial
structure (Campanella et al., 2008), thus affecting the inner mem-
brane organization and retention of cyt c.
In order to provide further proof that alterations in the mito-
chondrial ultrastructure can be involved in IF1-dependent tumor-
igenesis, we analyzed the topology of the MIM in IF1 KD and
control HeLa cells before and after induction of apoptosis (Fig-
ure 1E). Although no major changes in the organization of the
cristae were previously highlighted (Fujikawa et al., 2012), at a
closer examination we noticed that KD of IF1 yielded cells
with fewer mitochondrial cristae, which also appeared rather
disorganized (Figure 1F). This confirms that IF1 plays a part in
the structural stability of mitochondrial membranes. Moreover,
STS-induced cristae remodeling was more pronounced in IF1
KD cells (Figure 1F). This effect most probably depends on the
reduced level of mitochondrial inner membrane organization
observed.
Interestingly, a substantial reduction in cristae number was re-
corded in liver mitochondria from IF1 KOmicewhen compared to
the wild-type (WT) line (Figure S2D). In contrast to previous ex-
amination (Nakamura et al., 2013), the TEM analysis described
here revealed the presence of sizeable differences in mitochon-
drial morphology and ultrastructure between the two genetic
backgrounds. We collected quantitative data by measuring the
number ofmitochondria in each cell and assessing their morpho-
logical differences, as well as comparing the density of mito-
chondrial cristae. Indeed, IF1 ablation resulted in decreased
number of mitochondria, accompanied by volume enlargement
and cristae loss.
IF1 Regulates Both Structure and Function of
Mitochondria
Considering the effect of IF1 on both mitochondrial structure and
oncogenic potential of immortalized cells, we analyzed whether
the pro-survival potential of the protein could be related to its
inhibitory activity to ATP hydrolysis. For the purpose, we used
two different mutant clones obtained by introducing missense
mutations in the IF1 cDNA (Figure 2A). IF1
E30A carries a mutation
in the inhibitory domain that impedes both binding to and
regulation of the ATP synthase (Bason et al., 2011). In IF1
H49P,
pH-dependent regulation is affected instead, and the clone is
active even in the basic physiological conditions of the mito-
chondrial matrix environment (similar to the H49K substitution
[Cabezon et al., 2000; Sa´nchez-Cenizo et al., 2010]). Therefore,m). Data are presented as mean ± SEM; n = 4 (nine fields per dish).
itions and after treatment with STS (scale bars, 500 nm).
een distorted (horseshoe shaped, swollen, disorganized) and normal (lamellar
ted as mean ± SEM; n = 3 (20 cells per grid).
MEFs.
erage xenograft size.
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by complementing with endogenous IF1, the two clones behave
as dominant-negative (IF1
E30A) and constitutively active (IF1
H49P)
mutants. We first monitored the levels of active dimers and inac-
tive tetramers in transiently transfected HeLa cells (Figures S3A
and S3B). As expected, IF1
H49P transfected cells were character-
ized by a higher IF1 dimer:tetramer ratio, indicating an enhanced
rate of dissociation of active dimers from inactive oligomers even
at resting conditions.
Alteration inmitochondrial oxidativephosphorylation (OXPHOS)
efficiency induced by the expression of the two IF1 mutant clones
was then determined by measuring changes in the oxygen con-
sumption rate (OCR) and intracellular ATP levels in response to
mitochondrial toxins. OCR was measured in untreated cells and
upon challenge with oligomycin (OLG) to block ATP synthesis,
carbonyl cyanide 4-trifluoromethoxy-phenylhydrazone (FCCP) to
uncouple the MIM and a combination of rotenone (ROT), and
antimycin A (AMA) to arrest mitochondrial respiration (Figure 2B).
A luciferase assay was instead used to assess mitochondrial
and cytosolic free ATP levels before and after addition of OLG
(Figures 2C and S3E). Both assays revealed that mitochondrial
bioenergetic efficiency is positively and negatively modulated by
IF1
H49P and IF1
E30A, respectively. In fact, the dominant-negative
mutation (E30A) induced a decrease in the basal and maximal
respiration rates (Figure S3C), whichwas paralleled by a reduction
in the ATP synthase activity, as shown by its lower sensitivity to
OLG (Figures S3D and S3F). IF1
H49P, instead, had a greater effect
on mitochondrial respiration and ATP synthesis than the WT pro-
tein, indicating that the two mutants are effectively able to modify
the activity of endogenous IF1 by complementation.
Further proof of the different behavior of the IF1 mutant clones
was obtained by measuring the mitochondrial membrane poten-
tial (DJm) (Figure 2D). As widely reported, loss of IF1 function
produces an increase in DJm (Campanella et al., 2008; BarbatoFigure 2. Regulation of Mitochondrial Function and Structure by IF1 C
(A) Scheme of IF1 and mutant clones structures. MTS, mitochondrial targeting seq
rich region.
(B) Representative graph of OCR in HeLa cells exposed to OLG (1 mM), FCCP (0.5
content.
(C) Prototypical live-cell luciferase assay to measure basal intramitochondrial A
luciferase (mLuc) and challenged with OLG (2.5 mg/mL).
(D) Bar chart showing differences in basalDJm,measuredwith TMRM (30 nM), in H
fluorescent protein (YFP) to allow for fluorescence-based selection, and imaged
(E) Prototypical traces of DJm loss in HeLa cells exposed to NaCN. Cells w
TMRM (30 nM). TMRM emitted fluorescence was continuously monitored befor
confirm the directional behavior of the dye.
(F) Column diagram of mean TMRM intensity at plateau following NaCN treatmen
(G) Representative traces of Mag-Fura-2 fluorescence intensity in HeLa cells expre
1 mM NaCN and 2 mM IAA, no glucose, to mimic ischemia-induced, ATP syntha
Fura-2340/380 nm intensity ratio, which reflects the rise in [Mg
2+]c, was monitored
(H) Bar chart of mean slopes of increase in Mag-Fura-2 intensity ratio, calculated
n = 4 (13–20 cells per cover glass).
(I) Histogram reporting percentage of propidium iodide (PI) positive HeLa cells tra
(2-hr incubation with 1 mM NaCN, 2 mM IAA, no glucose). Data are presented a
(J) Representative images of mitochondrial network morphology in control HeL
(mtGFP) and the indicated constructs, and IF1 KD cells expressing mtGFP.
(K) Scatterplot showing the analysis of mitochondrial AR and FF. Higher values (up
ramification. Data are presented as mean ± SEM; n = 3 (seven to 15 cells per co
(L) Average percentage of apoptosis in control HeLa cells expressing different IF1
and the indicated construct and incubated with 1 mM STS for 12 hr. Apoptotic ce
(>500 cells per cover glass).et al., 2015), which was observed in cells transfected with
IF1
E30A. IF1
H49P instead induced a significant decrease in basal
DJm. Subsequent incubation with OLG confirmed that these
variations depend on interaction with the ATP synthase.
Finally, the inhibitory activities of the IF1 mutant clones were
evaluated by dynamically monitoring DJm and ATP levels in
HeLa cells subjected to NaCN-induced ischemia (Figures 2E
and 2G). The opposite responses to hypoxic-like conditions ex-
hibited by HeLa cells expressing the two IF1 mutant clones
further demonstrated the effective modulation of endogenous
IF1 inhibitory activity (Figures 2F and 2H). Since inhibition of the
ATP synthase reversal by IF1 has a protective role against
ischemic/hypoxic damage (Rouslin and Broge, 1996; Matic
et al., 2016), we then tested whether cells transfected with the
two mutant clones exhibit a different resistance to chemically
induced ischemia. As shown in Figure 2I, cells expressing
IF1
E30A were more susceptible than control cells to ischemia,
while IF1
H49P was instead protective.
We then examined the impact on the mitochondrial network
morphology by evaluating mitochondrial volume (profile area),
length (aspect ratio, AR), and degree of branching (form fac-
tor, FF). Interestingly, both mutant clones affected these param-
eters producing opposite outcomes (Figures 2J and S3G).
Indeed, IF1
E30A expressing HeLa cells were characterized by
reduced mitochondrial volume and fragmentation of the mito-
chondrial network, while constitutive activation of IF1 (IF1
H49P)
enhanced mitochondrial elongation and interconnectivity (Fig-
ures S3H and 2K). Furthermore, IF1 KD HeLa showed compa-
rable effects on AR and FF to the ones induced by IF1
E30A
(Figure 2K). The result further corroborates the hypothesis that
IF1 has a physiological role in assisting the shaping of the mito-
chondrial internal structure and network morphology by binding
the ATP synthase.lones
uence; ID, inhibitory domain; CBS, putative CaM-binding site; HRR, histidine-
mM), and ROT/AMA (1 mM). Values were normalized to themitochondrial protein
TP levels. HeLa cells were transiently transfected with mitochondria-targeted
eLa cells expressing different IF1 clones. Cells were co-transfected with yellow
before and after exposure to OLG (2.5 mg/mL, 20 min).
ere co-transfected with YFP and the indicated construct, and loaded with
e and after addition of NaCN (1 mM). FCCP (20 nM) was added at plateau to
t. Data are presented as mean ± SEM; n = 5 (seven to 12 cells per cover glass).
ssingWT andmutant IF1. Cells, co-transfected with YFP, were challengedwith
se reversal-driven depletion of cellular ATP. The subsequent increase in Mag-
as a readout of the degree of ATP synthase reversal.
via linearization, and fitting of raw traces. Data are presented as mean ± SEM;
nsfected with different IF1 mutant clones and subjected to chemical ischemia
s mean ± SEM; n = 3 (>400 cells per cover glass).
a cells, co-transfected with mitochondria-targeted green fluorescent protein
per-right part of the diagram) indicate increased mitochondrial elongation and
ver glass).
clones and IF1 KD cells treated with STS. Cells were co-transfected with dsRed
lls were stained with TUNEL assay. Data are presented as mean ± SEM; n = 4
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Figure 3. IF1 Impact on Mitochondrial Cristae Structure and Apoptotic Remodeling
(A) Representative western blot of STS-induced cleavage of OPA1 in control and IF1-overexpressing HeLa.
(B) Column diagrams reporting the density of band b (L2-OPA1) and the density ratio between bands e (S3-OPA1) and b at different time points of STS treatment.
Data are presented as mean ± SEM; n = 4.
(C) Prototypical fluorescent immunocytochemistry (ICC) images of OPA1/ MEFs transfected with either YFP or IF1-YFP and immunostained for ATP5B to
visualize the mitochondrial network (red). Nuclei were stained with DAPI.
(legend continued on next page)
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Changes in mitochondrial mass, such as those induced by
expression of WT and mutant IF1 clones, can directly cause
endoplasmic reticulum (ER) stress by affecting the mitochon-
dria-ER coupling and promoting loss of intraluminal Ca2+
through alterations in mitochondrial respiration, Ca2+ uptake,
and reactive oxygen species (ROS) production. For this reason,
the Ca2+ storing capacity of the ER following transfection with
the IF1 clones was monitored before proceeding through further
analysis. The comparable extents of passive Ca2+ release
induced by inhibiting the sarco-endoplasmic reticulum Ca2+
ATPase (SERCA) with thapsigargin ruled out the presence of al-
terations in the physiological interplay between mitochondria
and ER Ca2+ signaling (G.G., D.F., and M.C., unpublished data).
The IF1 mutant clones were finally tested for their capability
to counteract apoptosis triggered by staurosporine (STS)
(Figure 2L). While WT IF1 and IF1
H49P were equally effective
in reducing the extent of apoptosis independently from activa-
tion of the nuclear factor kB (NF-kB) pathway (Figures S4A
and S4B), IF1
E30A expression led to sensitization to apoptosis,
which was likewise observed in IF1 KD cells.
IF1 Prevents Apoptotic Remodeling of Mitochondria by
Inhibiting OMA1 Activation and OPA1 Processing
All the data collected so far corroborate previous evidence that
the expression level and activity of IF1 modulate mitochondrial
network structure and MIM topology (Campanella et al., 2008;
Faccenda et al., 2013b). The anti-apoptotic role of IF1 does
appear to primarily depend on this structural effect, as formerly
postulated (Faccenda et al., 2013a).
Therefore, we decided to assess the effect of IF1 on the
apoptotic cleavage of the pro-fusion protein OPA1, which is
required for the maintenance of cristae junctions (Frezza
et al., 2006). During apoptosis, the stress-induced cleavage of
L-OPA1 induces cristae junctions opening and release of pro-
apoptotic factors, such as cyt c, in the intermembrane space,
from where they are subsequently released into the cytosol
upon permeabilization of the mitochondrial outer membrane
(Scorrano et al., 2002).
STS-inducedOPA1processingwas therefore analyzed in con-
trol and IF1-overexpressing HeLa cells, bymonitoring apoptosis-
dependent loss of L2-OPA1 (band b) and accumulation of
S3-OPA1 (band e) (Griparic et al., 2007). As shown in Figure 3A,
in control cells L2-OPA1 was almost completely lost after 8 hr of
STS incubation. In IF1-overexpressing cells, instead, it was still
retained at 12 hr of STS incubation, and the extent of OPA1 pro-
cessing was almost halved after 12 hr (Figure 3B). Consistently,
loss of IF1 activity led to increased STS-induced OPA1 process-
ing (Figures S4C and S4D).(D) Bar chart of the average rate of apoptotic cell death inWT andOPA1/MEFs
stained with annexin V- phycoerythrin (PE) and 7-aminoactinomycin D (7-AAD) to
Data are presented as mean ± SEM; n = 3 (>200 cells per cover glass).
(E) Western blotting analysis of OMA1 activation in HeLa cells following 4-hr trea
(F) Bar chart reporting the STS-induced autocatalytic cleavage of active 40-kDa
(G) Western blotting analysis of OPA1 isoforms before and after 4-hr treatment w
(H) Bar charts of average density of band b and density ratio between bands e a
(I) Representative blot of 60- and 40-kDa OMA1 bands in HeLa cells transfected
(J) Bar chart of average density of the 40-kDa OMA1 band. Data are presented aTo verify whether the presence of OPA1 is necessary for the
anti-apoptotic activity of IF1, we monitored the effect of IF1
overexpression on mitochondrial morphology and resistance to
apoptosis in OPA1-null MEFs (Song et al., 2007). Downregula-
tion of OPA1 induces extensive mitochondrial fragmentation
and sensitizes cells to undergo apoptosis (Arnoult et al., 2005).
As shown in Figures 3C and 3D, the overexpression of IF1 was
ineffective in rescuing the pro-apoptotic phenotype of OPA1/
MEFs, suggesting that the structural role of IF1 on cristae
morphology does not overlap with OPA1 activity.
Interestingly, we also observed that increased IF1 activity
counteracts the activation of the MIM-embedded zinc metallo-
peptidase OMA1. OMA1, activation of which leads to full degra-
dation of L-OPA1, regulates the stress-induced processing of
OPA1 (Anand et al., 2014; Jiang et al., 2014). Even though the
OMA1-mediated proteolytic cleavage of OPA1is mainly trig-
gered by MIM depolarization (Zhang et al., 2014), the protein is
also activated during apoptosis, and knocking down the gene
confers a degree of resistance to cell death (Jiang et al., 2014).
Therefore, we investigated the proteolytic activity of OMA1 in
control and IF1-overexpressing cells treatedwith STS (Figure 3E).
In both cell types, STS induced a reduction in the levels of the
proteolitically active 43-kDa isoform of OMA1, indicating auto-
catalytic activation of the protein (Baker et al., 2014; Zhang
et al., 2014). Nevertheless, this was less pronounced in +IF1 cells
(Figure 3F).
As further proof that IF1 regulates OMA1-dependent apoptotic
processing of OPA1, inactivation of IF1 by expression of the
dominant-negative mutant clone (IF1
E30A) abolished the preser-
vation of OPA1 integrity during apoptosis observed in IF1-over-
expressing cells (Figures 3G and 3H), as well as counteraction
of apoptotic OMA1 activation (Figures 3I and 3J).
The OMA1 dependency of the IF1 protective activity against
apoptotic processing of OPA1 was also verified by showing
that downregulation of OMA1 completely prevents STS-induced
OPA1 cleavage in IF1-silenced HeLa cells (Figures S4E and S4J).
IF1 Triggers an ATP-Dependent Antioxidant Pathway
that Protects from Apoptotic Damage
A final aspect we took into examination is the impact of IF1 on the
cellular redox status of cancer cells. Reduced IF1 activity has
been linked to increasedmitochondrial ROS generation (Campa-
nella et al., 2009; Fujikawa et al., 2012). This event can directly
induce the proteolytic cleavage of OPA1 (Baker et al., 2014), a
phenomenon that is delayed both in IF1-overexpressing cells
and in presence of the mitochondria-targeted superoxide dis-
mutase (SOD) mimetic MitoTEMPO (Figures S4G and S4H). To
clarify whether IF1 plays an active role in the control of oxidativeafter 8-hr STS treatment. Cells were transfected with either YFP or IF1-YFP, and
evaluate the percentage of apoptotic dead cells (PE/7-AAD double-positive).
tment with STS.
OMA1 peptide. Data are presented as mean ± SEM; n = 4.
ith STS in HeLa expressing WT IF1 or the two mutant clones.
nd b. Data are presented as mean ± SEM; n = 3.
with WT IF1, IF1
E30A, or IF1
H49P and treated with 1 mM STS for 4 hr.
s mean ± SEM; n = 3.
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Figure 4. Regulation of Antioxidant
Response by IF1
(A) O2,
–-dependent increase in DHE emitted
fluorescence in HeLa cells expressing IF1 mutant
clones. Cells were co-transfected with YFP and
imaged in real time on a confocal microscope in
presence of 5 mMDHE, before and after addition of
500 nM ROT.
(B) Bar chart reporting mean slopes of increase
in DHE fluorescence intensity, before and after
treatment with ROT. Data are presented as
mean ± SEM; n = 3 (15–20 cells per cover glass).
(C) Mitochondrial ROS levels in HeLa cells modu-
lated for IF1 activity measured using MitoSOX
Red (5 mM, 10-min incubation). Mitochondrial O2,
–
generation was elicited by treatment with ROT
(500 nM, 45-min incubation). Preincubation with
MitoTEMPO was used as a control (20 mM, 45-min
incubation). Data are presented as mean ± SEM;
n = 4.
(D) Bar chart of percentage of increase in MitoSOX
Red fluorescence intensity after treatment with
ROT. Data are presented as mean ± SEM.
(E) GSH levels monitored using mBCL (20 mM) in
HeLa cells expressing IF1 mutant clones. The col-
umn diagram shows the average mBCl fluores-
cence intensity after 40-min incubation in untreated
cells (45 min Eth, vehicle control), after exposure to
ROT (500 nM for 45 min), and in cells pre-incu-
bated with a SOD mimetic (20 mM Mn(III)TMPyP or
20 mM MitoTEMPO for 1 hr) and then treated with
ROT (500 nMROT + 20 mMMn(III)TMPyP for 45min
or 500 nM ROT + 20 mM MitoTEMPO for 45 min).
Data are presented as mean ± SEM; n = 3 (from
quadruplicate wells).stress in cancer cells, cytosolic and mitochondrial superoxide
anion (O2,
–) levels were measured both in basal conditions and
upon treatment with ROT, to elicit mitochondrial ROS
generation (Figures 4A–4D). Both IF1 overexpression and the
constitutively active mutant clone (IF1
H49P) hindered ROT-
induced mitochondrial and cytosolic O2,
– accumulation. Disrup-
tion of IF1 inhibitory site (IF1
E30A) led instead to an evident
increase in cellular ROS both at steady state and after inhi-
bition of mitochondrial respiration. The mitochondrial origin
of ROS was confirmed by preincubation with MitoTEMPO
(Figure 4C).
We then measured the levels of reduced GSH in HeLa cells
expressing the two IF1 mutants and treated with ROT. GSH is
the prevalent non-protein thiol in cells and plays a key role for
the detoxification from H2O2 and protein hydroperoxides (Lu,
2009). Interestingly, we observed depletion of GSH levels in all
cell types after treatment with ROT (Figure 4E), but this was lower
in IF1
H49P-expressing cells. Pre-treatment with MitoTEMPO1876 Cell Reports 18, 1869–1883, February 21, 2017reduced the extent of ROT-induced
GSH loss, confirming the involvement of
mitochondrial ROS.
The effect of STS treatment on the
cellular antioxidant defense was then
evaluated by monitoring two antioxidant
systems, GSH and peroxiredoxins (Prxs).Prxs are a group of cysteine-dependent peroxidases involved in
scavenging H2O2 and peroxide substrates (Rhee et al., 2005).
Depletion of the GSH pool is an early event in apoptosis (Ghibelli
et al., 1998), during which it gets extruded and inactivated by
oxidation (Hammond et al., 2004; Franco et al., 2007). Along with
GSH, mitochondrial Prx3 also regulates cellular response to
oxidative stress-induced apoptosis (Chang et al., 2004) and is
rapidly oxidized during the process (Cox et al., 2008; Brown
et al., 2008).
STS-inducedGSHdepletionandPrxshyperoxidation (Prx-SO3)
were therefore evaluated (Figures 5A, 5C, and 5D). The results
identify a role for IF1 in maintenance of the antioxidant capacity
of cells during apoptosis. Indeed, differently from IF1 overexpres-
sion, inactivating IF1 (IF1
E30A) intensifiedGSH lossandhyperoxida-
tion of the mitochondrial Prx pool during STS-dependent
apoptosis. Cells transfected with IF1
E30A also showed increased
basal levels of hyperoxidized Prx when compared to cells overex-
pressing WT IF1, data that are consistent with the higher ROS
Figure 5. IF1 Preserves the Cellular Antioxidant Capacity during Apoptotic Stress
(A) Column diagram of mBCl fluorescence intensity in HeLa cells expressing WT IF1, IF1
E30A, or IF1
H49P. Cells were transfected as in previous mBCl assay and
treated with STS (1 mM) for 2 hr or incubated with MitoTEMPO (20 mM for 1 hr) prior to exposure to STS in the presence of the SOD mimetic (1 mM STS +
20 mMMitoTEMPO for 2 hr). To measure steady-state mBCl fluorescent, cells were incubated for 2 hr with DMSO (vehicle control). Data are presented as mean ±
SEM; n = 3 (from quadruplicate wells).
(B) STS-induced GSH loss measured via mBCl assay in cells pre-treated with ATR (100 mM, 1 hr) or OLG (2.5 mg/mL, 1 hr). The two compounds were also added
during the 2-hr incubation with STS. Data are presented as mean ± SEM; n = 3 (from quadruplicate wells).
(C) Representative western blot of mitochondrial Prx3 and Prx-SO3; apoptosis-dependent redox inactivation of Prx was induced by treating cells with 1 mM STS
for 4 hr.
(D) Column diagram of mean density of Prx3 and Prx-SO3 protein bands, before and after STS treatment. Data are presented as mean ± SEM; n = 3.
(legend continued on next page)
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production observed in these cells. Since bothGSHsynthesis and
re-activation of the hyperoxidized Prxs rely on ATP-dependent re-
actions (Lu, 2009), maintenance of the cellular antioxidant capac-
ity by IF1 can depend not only on reduction of mitochondrial ROS
generation, but also on increased availability of ATP, which is re-
tained in cells overexpressing IF1 after challengewithSTS (Figures
S4I andS4J). To test this hypothesis, STS-mediatedGSH lossand
Prx hyperoxidation were also measured in the presence of atrac-
tyloside (ATR), to inhibit themitochondrial import of ADPbyblock-
ing theADP/ATPcarrierprotein (AAC), orOLG (Figures5B,5E, and
5F). The protective effect of IF1 against STS-induced oxidative
damage was fully lost in cells co-treated with OLG, confirming
that the anti-apoptotic role of IF1 at least partially relies on preser-
vation of intracellular free ATP levels. Interestingly, ATR was
instead not effective in preventing the IF1-mediated preservation
of GSH and Prx. Since the AAC is the only mitochondrial ADP/
ATP translocase (Pebay-Peyroula et al., 2003), the result obtained
with ATRmay depend on residual high intramitochondrial levels of
ATP in cells transfected with WT IF1 or IF1
H49P.
As depicted in Figure 5G, IF1 plausibly participates in mainte-
nance of the cellular antioxidant defenses by both decreasing
the levels of peroxide substrates and guaranteeing the availabil-
ity of ATP for preservation of the cellular antioxidant capacity.
DISCUSSION
Numerous studies suggest that IF1 activates pro-survival
signaling pathways, induces resistance to cell death, and con-
fers the migratory phenotype in metastatic cancer (Formentini
et al., 2012; Faccenda et al., 2013b; Song et al., 2014; Yin
et al., 2015). Silencing of IF1 impairs HeLa cells proliferative ca-
pacity (Figures 1C and 1D) and blocks the transforming potential
of the protein (Figures 1G and 1H and S2C). Interestingly,
increased IF1 protein levels and IF1:ATP synthase expression ra-
tio, which characterizes highly metabolic tissues such as brain,
heart, and renal proximal tubule (Campanella et al., 2008; Hall
et al., 2009; Sa´nchez-Arago´ et al., 2013), was also observed at
higher tumor grades (Figures 1A and 1B). On the basis of previ-
ous work, we propose that IF1-mediated evasion of cell death re-
lies on preservation of the morphological integrity of mitochon-
dria and prevention of cristae disassembly (Faccenda et al.,
2013a). This was therefore examined in greater detail.
Indeed, loss of IF1 causes extensive morphological alteration
of themitochondrial ultrastructure, as originated from a quantita-
tive, in depth analysis of IF1 KD HeLa cells and hepatocytes from
IF1 KO mice. We noticed that silencing of IF1 induces formation
of abnormally shaped cristae with an arch-like profile (Figure 1E),
a phenotype that resembles the one produced by alterations of
the supramolecular assembly of the ATP synthase (Habersetzer
et al., 2013). This result was somewhat predictable, since there is
evidence of IF1 participating in the biogenesis and shaping of
mitochondrial cristae by promoting dimerization of the ATP syn-(E) Representative blot of cellular Prx hyperoxidation (Prx-SO3) in cells treated with
pre-incubated for 1 hr with the compounds prior to apoptosis induction (DMSO
(F) Bar chart of average Prx-SO3 density in the presence of ATR or OLG. Data ar
(G) Schematic representation of the GSH and Prx antioxidant pathways. Increa
mitochondrial ROS production and maintaining sufficient ATP levels for de novo
1878 Cell Reports 18, 1869–1883, February 21, 2017thase (Minauro-Sanmiguel et al., 2005). The collapse of the
organelle during apoptosis also appears to be enhanced (Fig-
ure 1F), due to the lower number of lamellar cristae, which facil-
itates cristae loss and remodeling of the MIM. Furthermore,
knocking out IF1 not only causes a reduction in mitochondrial
mass, but also induces slight enlargement of the organelle (Fig-
ure S2D), reducing the threshold for mitochondrial tolerance to
stress-induced swelling.
Considering previous findings and the data reported herein
substantiating a role for IF1 in the regulation of mitochondrial
morphology during apoptosis, we examined whether the IF1
expression level regulates the apoptotic cleavage of OPA1,
which controls formation and maintenance of cristae structure,
behaving as anti-apoptotic factor (Varanita et al., 2015). Our
results show that IF1 overexpression prevents STS-induced pro-
cessing of L2-OPA1 (Figures 3A and 3B), therefore limiting
cristae remodeling, which is an essential step of mitochondrial
commitment to apoptosis (Scorrano et al., 2002).
Recent work has proposed that apoptotic cleavage of OPA1
predominantly depends on stress-triggered activation of OMA1
(Anand et al., 2014; Zhang et al., 2014; Jiang et al., 2014). This
event is induced by various cellular stress signals, such as
decreased mitochondrial ATP levels, altered DJm and oxidative
stress (Baker et al., 2014; Bohovych et al., 2014; Zhang et al.,
2014), all of which often accompany apoptosis progression.
In this study, we show that IF1 preserves OPA1 integrity
during apoptosis by counteracting the autocatalytic cleavage
of OMA1 and, therefore, its proteolytic activity (Figures 3E
and 3F). IF1-regulated maintenance of intracellular ATP levels,
which is protective against both ischemic/hypoxic and apoptotic
damage (Figures 2H and 2K), can represent a potential mecha-
nism for impaired OMA1-mediated processing of OPA1.
However, an alternative explanatory mechanism for this is
linked with the ability of IF1 to activate an ATP-dependent antiox-
idant pathway, which relies on preservation of GSH and Prx ac-
tivity and is intimately involved with the anti-apoptotic function of
IF1 (Figure 5).
Oxidative stress has longbeenconsidered as one of the driving
forces in the tumorigenic process (Kensler and Trush, 1984; Bur-
don et al., 1990). However, increased cellular ROS production
must be tightly controlled, in order to avoid excessive cellular
damage that can lead to cell death. Due to higher levels of ROS
accumulation, cancer cells are closer to the threshold of redox
stress inwhichapoptosis is favoredover cell proliferation (Giorgio
et al., 2007).The role of IF1 onmitochondrial production of ROS in
cancer cells is still debatable. Reduced IF1 activity has been
correlatedwith higher levels of ROS (Campanella et al., 2009; Fu-
jikawaet al., 2012); however, augmentedmitochondrial ROSpro-
duction has also been observed in cancer cells overexpressing
IF1 (Formentini et al., 2012) and has been linked to activation of
a pro-survival retrograde response. In this study, we evaluated
the rate of O2,
– production in HeLa cells transfected with the1 mMSTS (4 hr) in the presence of ATR (100 mM) or OLG (2.5 mg/mL). Cells were
vehicle was used as control).
e presented as mean ± SEM; n = 3.
sed levels of IF1 may protect from STS-triggered ROS-damage by lowering
synthesis of GSH and Srx-dependent reactivation of hyperoxidized Prxs.
Figure 6. Working Model for the IF1-Medi-
ated Inhibition of OPA1 Processing and
Prxs Inactivation
The cartoon depicts the two stages of mitochon-
drial commitment to apoptosis and the contribu-
tion of IF1 to the oncogenic phenotype. In the left
panel, IF1 expression level affects mitochondrial
ultrastructure by modulating the rate of ATP syn-
thase dimerization, thereby altering the shape and
organization of cristae membranes. In the right
panel, inhibition of apoptosis by IF1 is presented.
Increased levels of IF1 improve the stability of
mitochondrial membranes, limiting both apoptotic
mitochondrial remodeling (dependent on the
processing of OPA1 by OMA1) and permeabiliza-
tion (which leads to cyt c release). Moreover, the
enzymatic efficiency of the ATP synthase is pre-
served, hindering ROS production and ATP loss.
Therefore, cellular antioxidant defenses are
conserved, and oxidative stress-induced tumor
suppression is counteracted.two IF1 mutant clones upon inhibition of complex I and observed
that ROS accumulation is reduced upon overexpression of IF1,
while cellular ROS levels are tangibly increased when IF1 activity
is compromised, and the ATP synthase reversal is unrestrained
(Figures 4A–4D). This might not only be a direct consequence
of the variation in the mitochondrial respiratory efficiency caused
by changes in IF1 levels (Figures 2B and 2C), but also partially
depend on the observed alteration in the mitochondrial network
morphology. Overexpression of the protein induces an increase
inmitochondrialmass andpromotes the elongation and intercon-
nectivity of the network (Figures 2J, 2K, S3G, and S3H), all of
which enhance mitochondrial function, thereby lowering the
rate of toxic ROS that are generated by inefficient respiration.
Indeed, both efficient mitochondrial dynamics and fusion of the
network favor mitochondrial respiratory capacity (Picard et al.,
2013), while excessive fragmentation is often accompanied by
high levels of ROS production (Yu et al., 2006, 2008).Cell RepoIn line with this, we observed that
the cellular levels of reduced GSH
vary accordingly to IF1 activity. Indeed,
oxidative depletion of the cellular GSH
pool following inhibition of mitochondrial
respiration and under STS treatment was
less pronounced in IF1-overexpressing
cells and in those transfected with the
constitutively active clone (Figures 4E
and 5A). Moreover, we showed that IF1
has a protective effect toward oxidative
inactivation of mitochondrial Prx, thus
confirming the antioxidant capacity of
IF1 (Figures 5C and 5D). Here, we showed
that increased IF1 activity reduces
apoptotic inactivation of Prx3 and can
therefore protect from ROS-dependent
apoptosis.
Considering that GSH synthesis from
glutamate and cysteine relies on an ATP-driven, two-step reaction (Lu, 2009), and reactivation of hyper-
oxidized Prx (Prx-SO3) is catalyzed by the ATP-dependent
enzyme sulfiredoxin (Srx) (Rhee et al., 2007), the identified
antioxidant activity of IF1 under stress conditions can rely on
maintenance of cellular ATP provision (Figures S5C and S5D).
Indeed, the protective effect of IF1 against STS-induced GSH
and Prx inactivation is lost upon administration of OLG (Figures
5B, 5E, and 5F), a potent inhibitor of the ATP synthase activity,
confirming that preservation of ATP synthesis is importantly
involved in the antioxidant and anti-apoptotic role of IF1.
Here, we prove that IF1, by targeting ATP dissipation, ulti-
mately protects from excessive oxidative stress (Figure 4G)
and ROS-induced cell death. As summarized in Figure 6, this
unveils a preferential mechanism for evasion of apoptosis and
acquisition of chemoresistance in tumor, via coordination of
mitochondrial bioenergetics and dynamics to retain mitochon-
drial function and membrane integrity.rts 18, 1869–1883, February 21, 2017 1879
EXPERIMENTAL PROCEDURES
Cell Culture
HeLa cervical adenocarcinoma cell line and MEFs were obtained from
the American Type Culture Collection (ATCC; https://www.atcc.org/). Stable
IF1 knockdown (IF1
KD) and scrambled control (Scrm) HeLa cell lines were
prepared as previously described (Fujikawa et al., 2012). IF1 KO MEFs were
prepared from IF1 KO mice (Nakamura et al., 2013). WT OPA1
/ MEFs
(Song et al., 2007) were kindly donated by Prof. Luca Scorrano (University of
Padua, Italy). All cell lines were cultured and prepared according to standard
mammalian tissue culture protocols (please refer to Supplemental Experi-
mental Procedures for details). All animal experiments were carried out ac-
cording to the correct institutional procedures.
Transfection and Gene Expression
Upregulation of IF1 was achieved by using the full-length ORF cDNA clone of
human ATPase inhibitory factor 1 (ATPIF1), transcript variant 1, mRNA (321 bp;
GenBank accession number: NM_016311.4), which was subcloned into the
MCS of the plasmidial vector pCMV-Sport6. The fluorescent-tagged version of
IF1 was obtained by subcloning of (cDNA) ATPIF1 into the MCS of the plasmidial
vectorpEYFP-N1,whichwascarriedoutbyMutagenex. IF1mutantclones (IF1
E30A
and IF1
H49P) were obtained from Mutagenex through site-directed mutagenesis
and subcloning of the mutated cDNAs into pEYFP-N1. The untagged versions
of themutant clones were obtained by subsequent deletion of the yellow fluores-
cent protein (YFP) coding sequence, which was equally realized by Mutagenex.
Depletion of IF1 and OMA1 expression in HeLa cells was instead achieved
by RNA interference technique, using the following mRNA-specific prede-
signed small interfering RNAs (siRNAs): human IF1 (Hs_ATPIF1_2 FlexiTube
siRNA) (QIAGEN, SI00308112) and human OMA1 (esiRNA1) (Sigma-Aldrich,
Mission esiRNA EHU072451).
Transfection with the appropriate cDNA or siRNA was carried out 36–48 hr
prior to experimentation using the calcium phosphate method. HeLa were
transfected when 50%–60% confluent, while MEFs at 30%–40% confluence.
Fluorescence Immunohistochemistry Analysis of Breast Cancer
TMAs
Slideswere deparaffinized in xylene, rehydrated, and incubated in citrate buffer
for heat-induced epitope retrieval. After cell permeabilization in 0.025% Triton
X-100 in Tris-buffered saline (TBS), slides were incubated with blocking
solution (10% normal goat serum [NGS], 1% BSA in TBS) for 2 hr at room
temperature (RT). Overnight incubation at 4Cwith a-IF1 and a-ATP5B primary
antibodieswas followedby1-hr treatment atRT in thedarkwith the appropriate
fluorescently labeled secondary antibodies (see Supplemental Experimental
Procedures). All antibodies were diluted in TBS supplemented with 1% BSA.
Nuclear staining was carried out with DAPI. Images were acquired using a
Leica DM IRB inverted fluorescence microscope. Analysis was conducted
with Volocity and heatmaps prepared on ImageJ.
Soft Agar Colony Formation Assay
6-well plates were filled with 1.5 mL of 0.6% low melting point agarose in
DMEM supplemented with 5% fetal bovine serum (FBS) as a bottom layer.
Control and IF1 KD HeLa cells, suspended in 0.6% agarose, were plated
on the upper layer of soft agar (5,000 cells/well). Viable colonies (>100 mm)
were manually counted in nine random areas per well under a microscope.
Analysis of Mitochondrial Inner Structure
After 4 hr STS treatment, control and IF1 KD HeLa (grown on cover glasses)
were immediately fixed and processed for transmission electron microscopy
(please refer to Supplemental Experimental Procedures). Images were ac-
quired using a JEOL JEM-1010 transmission electron microscope. Analysis
of cristae density was done in ImageJ and reported as number of cristae per
unit of mitochondrial area (the total number of cristae was divided by the entire
mitochondrial cross sectional area).
Xenograft Tumor Analysis
All xenograft procedures were conducted according to the correct institutional
procedures (approved by Kyoto Sangyo University). MEF cell lines were estab-1880 Cell Reports 18, 1869–1883, February 21, 2017lished from WT and IF1 KO mouse embryos (Nakamura et al., 2013) and then
transformed by retroviral infection of H-RasV12. Cell growth of transformed IF1
KOMEFswas confirmed to be equal to that of theWT counterpart, as shown in
Figure S1B. 1 3 107 immortalized MEF cells in 100 mL of PBS were grafted to
right (WT) and left (IF1 KO) side of six nudemice. After 20 days, growth of tumor
of nude mice was recorded.
Determination of Cellular OCR
On the day before experiment, HeLa cells, transfected with an empty plasmid
(as control) or with one IF1 construct (WT IF1, IF1
E30A, IF1
H49P), were seeded in
triplicate on Seahorse XFp cell-culture miniplates (33 104 cells per well). OCR
was measured with a Seahorse XFp extracellular flux analyzer, using a Sea-
horse XFp cell mito stress test kit and following manufacturer’s instructions
(as reported in Supplemental Experimental Procedures).
Data obtained from the assay were analyzed with the Seahorse XFp analysis
software and normalized to the amount of mitochondrial protein of each
sample, in order to avoid misinterpretation of data due to differences in mito-
chondrial mass between samples (as explained in Supplemental Experimental
Procedures).
Live-Cell Luciferase Assay
The comparison of basal levels of free cytosolic and mitochondrial ATP was
achieved by using targeted luciferase constructs.
HeLa cells were co-transfected with cytosol- or mitochondria-targeted lucif-
erase (cLuc ormLuc) and IF1, IF1
E30A, IF1
H49P, or an empty plasmid (as control).
After 36–48 hr from transfection, cells were transferred into the thermostatted
perfusion chamber of a custom built luminometer, and photon emission was
measured before and after addition of 20 mM D-luciferin. Once the ATP-
dependent luminescent signal had reached a plateau, 2.5 mg/mL OLG was
added to evaluate the contribution of the ATP synthase to cytosolic and mito-
chondrial ATP levels.
Measurement of DJm
Continuous monitoring of NaCN-induced mitochondrial depolarization was
achieved by loading cells with the fluorescent potentiometric dye tetramethyl
rodamine methyl ester (TMRM).
Cells were co-transfected with YFP andWT IF1, IF1
E30A, or IF1
H49P (an empty
plasmid was used as control) and loaded with 30 nM TMRM prior to experi-
ment. Cells were imaged using a Nikon Eclipse Ti-E inverted fluorescence mi-
croscope, and mitochondrial TMRM fluorescence decay was monitored in
real-time after administration of 1 mM NaCN until a plateau. Directional dye
behavior was confirmed by adding FCCP (20 nM). Settings were kept constant
between experiments. Time series were analyzed using Andor iQ2.
Measurement of Cellular ATP Depletion
[ATP]i was indirectly measured by using UV-excitable Mag-Fura-2, AM (please
refer to Supplemental Experimental Procedures). Cells were transfected as for
TMRM analysis and, before imaging, incubated with 5 mMMag-Fura-2. Exper-
iments were conducted in glucose-free medium (GFM), and ATP depletion
was induced by adding iodoacetic acid (IAA; 2 mM) and NaCN (1 mM). Time
series were acquired using a Nikon Eclipse Ti-E inverted fluorescence micro-
scope, and changes in Mag-Fura-2340/380 nm emission intensity ratio was then
recorded until a plateau. Settings were kept constant between experiments.
Images were processed and analyzed using Andor iQ2. Line slopes were
calculated through data linearization and fitting (linear interpolation).
Evaluation of Cell Death and Apoptosis Rates
The rate of cell death in ischemic-like conditions wasmeasuredwith combined
propidium iodide (PI)-DAPI nuclear stain (CPD). HeLa cells grown on 6-well
plates were co-transfected with YFP and either one of the IF1 constructs
(WT IF1, IF1
E30A, or IF1
H49P) or an empty plasmid (as control). 2-hr incubation
in ischemic buffer (GFM supplemented with 1 mM NaCN and 2 mM IAA)
was carried out 36–48 hr after transfection. CPD procedure was performed
directly after treatment (see Supplemental Experimental Procedures). Identifi-
cation of apoptotic cells was carried out with either terminal deoxynucleotidyl
transferase (TdT) dUTP nick-end labeling (TUNEL) assay or annexin V-phyco-
erythrin (PE) and 7-aminoactinomycin D (7-AAD) double stain, using a Leica
DM IRB inverted fluorescence microscope (see Supplemental Experimental
Procedures).
Analysis of Mitochondrial Morphology
Fluorescent immunocytochemistry (ICC) analysis of themitochondrial network
in OPA1/MEFs was carried out after transfection with either IF1-YFP or YFP
(as control). Cells were fixed in 4% paraformaldehyde (PFA) in PBS and
permeabilized in 0.1% Triton X-100. Blocking was carried out for 1 hr at RT
in 10% NGS, 3% BSA, and 0.01% Triton X-100 in PBS. Cells were then
incubated overnight with a-ATP5B antibody at 4C in blocking solution in a
humidified chamber and for 1 hr at RT with the appropriate fluorescently
tagged secondary antibody. 300 nMDAPI in PBSwas used for nuclear staining
(10 min at RT in the dark).
Mitochondrial profile area was assessed in cells transfected with either one
of the YFP-tagged IF1 constructs (IF1
WT-YFP, IF1
E30A-YFP, IF1
H49P-YFP) or
YFP (as control), by usingMitoTracker Red FM (50 nM). z stacks of transfected
cellswere obtained using a Zeiss LSM510 confocal laser scanningmicroscope
(CLSM). The number of slices and step size were kept constant, and themicro-
scope detection settings were fixed. The mitochondrial profile area (% of cyto-
solic volume occupied by mitochondria) was calculated with Volocity.
The shape descriptors aspect ratio (AR) and form factor (FF) were also evalu-
atedasmeasuresofmitochondrial elongationandbranching, respectively. Cells,
co-transfected with mitochondria-targeted green fluorescent protein (mtGFP),
were imagedusingaLeicaTCSSP5CLSM. zstackswereacquiredasdescripted
above. Image analysis and calculation of shape descriptors was done in ImageJ.
Sample Protein Preparation and Western Blot Analysis
Cells were grown on 10-cm plates in order to reach 80%–85% confluence
before treatment and lysis.
Chemical cross-linking for studying IF1 oligomerization was carried out prior
to cell lysis with the lipid-soluble cross-linker 1,5-difluoro-2,4-dinitrobenzene
(DFDNB). Protocols are reported in Supplemental Experimental Procedures.
Protein concentration was quantified using a BCA protein assay kit. Equal
amounts of protein (20 mg) were resolved on SDS-PAGE gels and transferred
to nitrocellulose membranes. After blocking, the membranes were incubated
overnight at 4C with the appropriate primary antibody and then for 1 hr at
RT with the corresponding peroxidase-conjugated secondary antibody (all
antibodies are listed in Supplemental Experimental Procedures). Immunoreac-
tive bands were analyzed with ImageJ software.
Measurement of O2,
– Levels
Cytosolic O2,
– levels were measured with dihydroethidium (DHE). Cells were
co-transfected with YFP and WT IF1, IF1
E30A, IF1
H49P or an empty plasmid
(as control) and imaged using a Zeiss LSM 510 CLSM confocal microscope.
5 mMDHEwas added, and its fluorescence increase was recorded for approx-
imately 10 min before challenge with 500 nM ROT (ROT). The same settings
were used in all experiments, and the slopes of the generated curves were
calculated through linear regression.
Analysis of ROT-induced mitochondrial ROS production was performed
with MitoSOX Red (5 mM), by comparing the intensity of its fluorescent signal
within mitochondria in untreated and ROT-treated cells.
Determination of Cellular GSH Levels with Monochlorobimane
Monochlorobimane (mBCl) assay was performed using a 96-well plate and a
Tecan Infinite M200 PRO microplate reader.
Cells were co-transfected with YFP cDNA andWT IF1, IF1
E30A, or IF1
E30A (an
empty plasmid was used as control). Before experiment, cells were trypsi-
nized, counted, and resuspended in recording medium (RM) at a standard
concentration of 13 106 cells/mL. 13 105 cells were then added in octuplicate
wells. 20 mM mBCl was then concomitantly added to all sample wells with a
multichannel pipette, and the plate was inserted into the microplate reader,
setting constant temperature of 37C and 5%CO2. The mBCl emitted fluores-
cence intensity was measured every 10 min over a 40-min period.
Measurement of Mitochondrial ATP Depletion
[ATP]m was measured via a luciferin-luciferase assay. HeLa cells were co-
transfected with IF1 (or an empty plasmid as control) andmLuc. Cells were firstperfused with RM supplemented with 100 mM luciferin, and proton counting
was carried out with a custom-built luminometer. Following stabilization of
the luminescent signal, cells were continuously exposed to luciferin (100 mM)
and STS (1 mM).
Statistical Analysis
Statistical analyses were performed using Prism 6. Data are presented as
mean ± SEM. Variations between three or more independent groups were
determined using one-way ANOVA. In case of rejection of the null hypothesis,
determination of which groups differ from each other (post hoc test) was
completed using the Tukey’s honest significant difference (HSD) test. A p value
of less than 0.05 was considered significant (*p < 0.05; **p < 0.01; ***p < 0.001).
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